Product Name :ERK1/2 (Phospho-T202/T185) Rabbit monoclonal antibody
Swiss-Prot :P27361; P28482
Application_all :WB (1/500 - 1/1000), IP (1/10 - 1/50)
Background :Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs, such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (Erk1/2) signaling pathway can be activated in response to a diverse range of extracellular stimuli, including mitogens, growth factors, and cytokines, and research investigators consider it an important target in the diagnosis and treatment of cancer. Upon stimulation, a sequential three-part protein kinase cascade is initiated, consisting of a MAP kinase kinase kinase (MAPKKK or MAP3K), a MAP kinase kinase (MAPKK or MAP2K), and a MAP kinase (MAPK). Multiple p44/42 MAP3Ks have been identified, including members of the Raf family, as well as Mos and Tpl2/COT. MEK1 and MEK2 are the primary MAPKKs in this pathway. MEK1 and MEK2 activate p44 and p42 through phosphorylation of activation loop residues Thr202/Tyr204 and Thr185/Tyr187, respectively. Several downstream targets of p44/42 have been identified, including p90RSK and the transcription factor Elk-1. p44/42 are negatively regulated by a family of dual-specificity (Thr/Tyr) MAPK phosphatases, known as DUSPs or MKPs, along with MEK inhibitors, such as U0126 and PD98059.
Product :Liquid in 50mM Tris-Glycine (pH 7.4), 0.15M NaCl, 50% Glycerol, 0.01% Sodium azide and 0.05% BSA.
Purification&Purity :The antibody was purified by immunogen affinity chromatography.
Storage&Stability :Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :Recognizes endogenous levels of ERK1/2 (pT202/T185) protein.
Note :For research use only, not for use in diagnostic procedure.
Pathway :Tumor Angiogenesis,Regulation of Apoptosis,ESC Pluripotency and Differentiation Signaling Pathway,Regulation of Microtubule Dynamics,ErbB HER Signaling,MAPK Erk in Growth and Differentiation Pathway,Inhibition of Apoptosis,Insulin &Glucose Signaling,Mitochondrial Control of Apoptosis,T cell receptor signaling,TGFβ Smad signaling,MTOR signaling,Jak Stat,Warburg Effect,IL-6 Receptor Signaling,Translational Contral elF4 and p70 S6 Kinase
Alternative Name :MAPK3; ERK1; PRKM3; Mitogen-activated protein kinase 3; MAP kinase 3; MAPK 3; ERT2; Extracellular signal-regulated kinase 1; ERK-1; Insulin-stimulated MAP2 kinase; MAP kinase isoform p44; p44-MAPK; Microtubule-associated protein 2 kinase; p44-ERK1; MAPK1; ERK2; PRKM1; PRKM2; Mitogen-activated protein kinase 1; MAP kinase 1; MAPK 1; ERT1; Extracellular signal-regulated kinase 2; ERK-2; MAP kinase isoform p42; p42-MAPK; Mitogen-activated protein kinase 2; MAP kinase 2; MAPK 2
Immunogen :A synthetic phosphopeptide corresponding to residues surrounding Thr202 of human ERK1
Modification :Phosphorylation
